CD8A and breast carcinoma: In contrast, an elevated level of CD8+ Tsen to 64.8% was observed in a 66-year-old patient with breast cancer with solitary lung metastasis who had previously been administrated with multiple cytotoxic agents and was currently treated with abemaciclib (Fig. 1d).